Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
16 Sep 2020
Historique:
received: 20 04 2020
accepted: 08 09 2020
entrez: 17 9 2020
pubmed: 18 9 2020
medline: 21 10 2020
Statut: epublish

Résumé

Person-centred care, an internationally recognised priority, describes the involvement of people in their care and treatment decisions, and the consideration of their needs and priorities within service delivery. Clarity is required regarding how it may be implemented in practice within different contexts. The standard multi-drug resistant tuberculosis (MDR-TB) treatment regimen is lengthy, toxic and insufficiently effective. 2019 World Health Organisation guidelines include a shorter (9-11-month) regimen and recommend that people with MDR-TB be involved in the choice of treatment option. We examine the perspectives and experiences of people with MDR-TB and health-care workers (HCW) regarding person-centred care in an MDR-TB programme in Karakalpakstan, Uzbekistan, run by Médecins Sans Frontières and the Ministry of Health. A qualitative study comprising 48 interviews with 24 people with MDR-TB and 20 HCW was conducted in June-July 2019. Participants were recruited purposively to include a range of treatment-taking experiences and professional positions. Interview data were analysed thematically using coding to identify emerging patterns, concepts, and categories relating to person-centred care, with Nvivo12. People with MDR-TB were unfamiliar with shared decision-making and felt uncomfortable taking responsibility for their treatment choice. HCW were viewed as having greater knowledge and expertise, and patients trusted HCW to act in their best interests, deferring the choice of appropriate treatment course to them. HCW had concerns about involving people in treatment choices, preferring that doctors made decisions. People with MDR-TB wanted to be involved in discussions about their treatment, and have their preference sought, and were comfortable choosing whether treatment was ambulatory or hospital-based. Participants felt it important that people with MDR-TB had knowledge and understanding about their treatment and disease, to foster their sense of preparedness and ownership for treatment. Involving people in their care was said to motivate sustained treatment-taking, and it appeared important to have evidence of treatment need and effect. There is a preference for doctors choosing the treatment regimen, linked to shared decision-making unfamiliarity and practitioner-patient knowledge imbalance. Involving people in their care, through discussions, information, and preference-seeking could foster ownership and self-responsibility, supporting sustained engagement with treatment.

Identifiants

pubmed: 32938422
doi: 10.1186/s12879-020-05407-7
pii: 10.1186/s12879-020-05407-7
pmc: PMC7493896
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

675

Références

BMJ. 1994 Jul 16;309(6948):184-8
pubmed: 8044100
Int J Tuberc Lung Dis. 2016 Aug;20(8):1084-90
pubmed: 27393544
Anthropol Med. 2013;20(2):160-74
pubmed: 23898836
J Nurs Scholarsh. 2012 Jun;44(2):136-44
pubmed: 22551013
Lancet Infect Dis. 2018 Jul;18(7):e183-e198
pubmed: 29580819
Eur Respir Rev. 2019 May 29;28(152):
pubmed: 31142549
Sociol Health Illn. 2017 May;39(4):599-613
pubmed: 27862018
PLoS One. 2018 Sep 14;13(9):e0203888
pubmed: 30216368
Milbank Q. 2001;79(4):613-39, v
pubmed: 11789119
Am J Orthopsychiatry. 1951 Jul;21(3):452-60
pubmed: 14857123
Disabil Rehabil. 2007 Oct 30-Nov 15;29(20-21):1555-65
pubmed: 17922326
Afr J AIDS Res. 2018 Sep;17(3):217-225
pubmed: 30132397
Health Syst Transit. 2014;16(5):1-137, xiii
pubmed: 25689490
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Fam Pract. 2003 Dec;20(6):724-9
pubmed: 14701899
Lancet Glob Health. 2014 Apr;2(4):e189-90
pubmed: 25103049
BMC Infect Dis. 2016 Jul 28;16:362
pubmed: 27465783
Lancet. 2019 Sep 14;394(10202):953-966
pubmed: 31526739
J Bras Pneumol. 2018 Apr;44(2):153-160
pubmed: 29791557
Ann Oncol. 2013 Sep;24(9):2444-9
pubmed: 23704195
Eur J Cardiovasc Nurs. 2011 Dec;10(4):248-51
pubmed: 21764386
Int J Tuberc Lung Dis. 2016 Apr;20(4):430-4
pubmed: 26970149
J Clin Nurs. 2013 Feb;22(3-4):456-65
pubmed: 23231540
Bull World Health Organ. 2014 Jan 1;92(1):68-74
pubmed: 24391302

Auteurs

Shona Horter (S)

Médecins Sans Frontières, Chancery Exchange, 10 Furnival Street, London, EC4A 1AB, UK. Shona_horter@yahoo.co.uk.

Beverley Stringer (B)

Médecins Sans Frontières, Chancery Exchange, 10 Furnival Street, London, EC4A 1AB, UK.

Nell Gray (N)

Médecins Sans Frontières, Chancery Exchange, 10 Furnival Street, London, EC4A 1AB, UK.

Nargiza Parpieva (N)

RSSPMCPh&P, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan.

Khasan Safaev (K)

RSSPMCPh&P, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan.

Zinaida Tigay (Z)

Republican Phtiziology Hospital #2, Ministry of Health of Karakalpakstan, Nukus, Uzbekistan.

Jatinder Singh (J)

Médecins Sans Frontières, Tashkent, Uzbekistan.

Jay Achar (J)

Médecins Sans Frontières, Chancery Exchange, 10 Furnival Street, London, EC4A 1AB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH